The Desmond Tutu TB Centre (www.sun.ac.za/tb) is an academic research centre of the Department of Paediatrics and Child Health, Faculty of Health Sciences. It has its main offices on the Tygerberg Campus and satellite offices in various communities affected by TB and poor health.
It has as its mission the improvement of the health of vulnerable groups through influencing policy based on new knowledge created by research focusing on health, mainly TB and HIV. To achieve this, the Centre works closely with the Department of Health and the local communities. It provides training to academic and health services staff, builds capacity in the University and the Department of Health, provides service to communities and advocates for TB and health. Himself a former TB sufferer, Archbishop Desmond Tutu champions tuberculosis research and care. He is also the patron of the on-campus Tygerberg Children's Hospital.
DTTC News
TWO SITE OFFICES DONATED FOR BUSY TB CLINICS Stellenbosch University's Desmond Tutu TB Centre has donated two site offices to clinics near Mbekweni, Paarl and Kayamandi, Stellenbosch as part of its goal to try to lower the high rate of TB in communities in the Western Cape. Read more...
WORKING TOGETHER TO MAKE A DIFFERENCE ORAP programme brings together researchers and health professionals
Medical researchers from universities and institutions across the country recently joined forces with health professionals from all nine provinces in an intensive and invigorating workshop at Erinvale in Somerset West. Read more...
GERRY ELSDON HITS THE ROAD IN SUPPORT OF TB AWARENESS Celebrity and Global TB Ambassador, Gerry Elsdon has been striding out to raise awareness of TB by traveling to South Africa's nine provinces and visiting people in communities, prisons, clinics and taxi ranks along the way. Read more...
THE ARCH GETS ON HIS BIKE TO SHOW SUPPORT FOR THE PUSH AGAINST CHILDHOOD TB South African Archbishop Emeritus, Desmond Tutu, has pulled on lycra shorts and a cycling shirt and jumped on a bike to support doctors and researchers who are riding in the Cape Argus Pick 'n Pay Cycle Tour to raise awareness of childhood TB. Read more...
PopArt The PopART (Population Anti-retroviral Treatment)trial is a collaboration between the London School of Hygiene and Tropical Medicine (LSHTM) in The United Kingdom, The Zambia AIDS Related Tuberculosis project ( ZAMBART) in Zambia, Imperial College London and our Desmond Tutu TB Centre (DTTC), South Africa. This trial has been jointly funded by The National Institute of Allergy and Infectious Disease (NIAID), the National Institute of Mental Health (NIMH), the Office of the United States Global AIDS co-ordinator (OGAC) and the Bill and Melinda Gates Foundation. Read more...
THE POIGNANCY OF TB BROUGHT TO LIFE ON STAGE The tragedy of dying of tuberculosis has been brought home in a creative and poignant way, with the staging of the world premiere of La Bohéme Abanxaxni in Cape Town. Instead of Puccini’s famous opera being set amongs the struggling artist community in 1930s Paris, the Isango Ensemble's production is set in the streets of Khayelithsa, where TB is as real today as it was 160 years after La Bohéme was written. The main character in the opera, Mimi, falls ill and ultimately dies of TB. Read more...
TB FREE KIDS One of the objectives of the TB Free Kids Project is to strengthen social capital. In contexts of poor health and limited resources, the development of sustainable partnerships is the only way of ensuring lasting impact. Given the links between poor health outcomes, low levels of literacy and high unemployment, Education must be a National Priority. To this end TB Free Kids have partnered with Symphonia for SA, bringing their School @ Centre of Community (S@CC) Project into the Ravensmead/Uitsig area and surrounds. Read more...
MDR-TB TRIALS COULD MAKE A TANGIBLE DIFFFERENCE FOR CHILDREN A team from Stellenbosch University's Desmond Tutu TB Centre will be monitoring 200 children at the Brooklyn Chest Hospital in Cape Town over the next five years in a potentially groundbreaking trial. Read more...
